Desk›Healthcare› Ind-Swift Laboratories Ltd
Ind-Swift Laboratories Ltd
BSE 532305 · NSE INDSWFTLAB · ISIN INE915B01019 · Group B · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹358.10
-2.62%
BSE close, 28 August 2026
₹3,114.09 cr
8.7 cr shares · Micro cap
₹1,751.63 cr
as published
52.9× · 3.09×
EPS ₹6.77 · BV ₹115.89
635.89 / 42.56
₹ cr, as filed
34
6 selected · 18%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -4.2% |
|---|---|
| Against 52-week low | +311.6% |
| Day change | -2.62% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹6.77 |
|---|---|
| Price / earnings | 52.90× |
| Price / book | 3.09× |
| Book value — derived, price ÷ P/B | ₹115.89 |
| Return on equity | 5.84% |
| Operating margin | 21.88% |
| Net margin | 13.14% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 5.84%
- ROE as published
- 5.84%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 186.08 | 24.44 | 2.81 | 21.88% | 13.14% |
| Mar-26 · Q | 172.70 | 14.94 | 1.79 | 10.05% | 8.65% |
| FY25-26 | 635.89 | 42.56 | 5.09 | 12.92% | 6.69% |
Quarter on quarter
- Revenue, quarter on quarter
- +7.7%
- Net profit, quarter on quarter
- +63.6%
- Operating margin, quarter on quarter
- +1,183 bps
Disclosure profile 34 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Press Release | 2 |
| Board Outcome | 1 |
| Concall Transcript | 1 |
| Investor Presentation | 1 |
| Results | 1 |
| Selected sub-total | 6 |
| Procedural | |
| General | 8 |
| AGM / EGM | 5 |
| Analyst / Investor Meet | 2 |
| Newspaper Publication | 2 |
| Allotment | 1 |
| Board Meeting | 1 |
| Charter Amendment | 1 |
| Clarification | 1 |
| Compliance Certificate | 1 |
| Corporate Action | 1 |
| Monitoring Agency | 1 |
| Other Update | 1 |
| Outcome | 1 |
| SAST | 1 |
| Trading Window | 1 |
| Procedural sub-total | 28 |
| Total | 34 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
34 filings · 6 selected · busiest 2026-08-10 and 2026-08-12
Filing rhythm · the twelve most recent
2026-09-042026-10-08
SelectedProcedural
Filings
34 in the window · 9 earlier on record
-
8 October 2026 ·
Conversion of Securities
Please find outcome of Preferential Issue Committee Meeting held on Oct. 08, 2026
Corp Action / Conversion of Securities View filing →
-
6 October 2026 ·
Newspaper Publication
Please find enclosed newspaper clippings informing stakeholders regarding special window for relodgement of physical shares
Company Update / Newspaper Publication View filing →
-
5 October 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Please find enclosed scrutiniser's report along with voting results for the 31st AGM, held on 30th September, 2026
AGM/EGM / AGM View filing →
-
5 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please refer the attached pdf
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
30 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Please find enclosed proceedings of the 31st Annual General Meeting of the company held on Wednesday, 30th Sept., 2026.
AGM/EGM / AGM View filing →
-
28 September 2026 ·
Intimation To The Shareholders Of Physical Securities Pursuant To SEBI Master Circular No. SEBI/HO/MIRSD/POD-1/P/CIR/2024/37 Dated May 07, 2024
Please refer attached pdf
Company Update / General View filing →
-
28 September 2026 ·
Closure of Trading Window
Please refer the attached pdf.
Insider Trading / SAST / Closure of Trading Window View filing →
-
23 September 2026 ·
Analyst / Investor Meet - Intimation
Please find enclosed Schedule of Analyst / Investor Meet scheduled to be held on Tuesday, 29th September, 2026, at 01.00 P.M. IST
Company Update / Analyst / Investor Meet View filing →
-
22 September 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Essix Biosciences Ltd & Others
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
21 September 2026 ·
Disclosures Under Regulation 29(2) Of The SEBI (Substantial Acquisition Of Shares And Takeover) Regulations, 2011
Please refer attached pdf.
Company Update / General View filing →
-
17 September 2026 ·
Allotment
Outcome of Preferential Issue Committee for Allotment of 70,00,000 Fully Convertible Warrants on Preferential Basis
Company Update / Allotment of Equity Shares View filing →
-
4 September 2026 ·
Newspaper Publication
Please refer attached newspaper publication dated 04.09.2026.
Company Update / Newspaper Publication View filing →
-
4 September 2026 ·
Outcome Of Preferential Issue Committee Meeting Held On Friday, 4Th September, 2026, As Per Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Please refer attached pdf.
Company Update / General View filing →
-
2 September 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting Held On September 02, 2026
Please find enclosed outcome of Board Meeting held on September 02, 2026.
Others / Outcome without intimation View filing →
-
27 August 2026 ·
Clarification On Movement In Volume
Please refer attached pdf regarding clarification sought from company regarding movement in value .
Company Update / General View filing →
-
27 August 2026 ·
Clarification sought from Ind-Swift Laboratories Ltd
The Exchange has sought clarification from Ind-Swift Laboratories Ltd on August 27, 2026, with reference to Movement in Volume. The reply is awaited.
Company Update / Clarification
-
20 August 2026 ·
Earnings Call Transcript
Please find enclosed Transcript of Earning Call held on August 17, 2026.
Company Update / Earnings Call Transcript View filing →
-
18 August 2026 ·
Press Release / Media Release
Please find enclosed press release titled as Ind-Swift to make Jammu facility EUGMP and PICS Compliant targets additional revenue of 100 crores from 2029-30 onwards .
Company Update / Press Release / Media Release View filing →
-
17 August 2026 ·
Audio Recording Of Earning Conference Call Held On 17.08.2026.
Audio recording of earning conference call held on 17.08.2026 on un-audited financial results for the quarter ended 30.06.2026.
Company Update / General View filing →
-
17 August 2026 ·
Investor Presentation
Please find attached intimation regarding the investor presentation on un-audited financial results for the quarter ended June, 30 2026.
Company Update / Investor Presentation View filing →
-
12 August 2026 ·
Analyst / Investor Meet - Intimation
Please find enclosed Schedule of Analyst / Investor Meet will be held on Monday, 17th August, 2026, at 03.00 P.M. IST in respect of financial results of the Company for the quarter ended ....
Company Update / Analyst / Investor Meet View filing →
-
12 August 2026 ·
Monitoring Agency Report
Please find enclosed report of the Monitoring Agency for the quarter ended June 30, 2026.
Company Update / Monitoring Agency Report View filing →
-
12 August 2026 ·
Press Release / Media Release
Please refer attached pdf .
Company Update / Press Release / Media Release View filing →
-
10 August 2026 ·
Financial Results For The Quarter Ended June 30, 2026
please refer attached pdf.
Result / Financial Results View filing →
-
10 August 2026 ·
Statement Of NIL Deviation Or Variation Under Reg. 32
Please find enclosed Statement of NIL Deviation for the Quarter ended June 30, 2026
Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation View filing →
-
10 August 2026 ·
Board Meeting Outcome for OUTCOME OF BOARD MEETING DATED AUGUST 10, 2026
Please find enclosed outcome of the Board Meeting Dated August 10, 2026
Board Meeting / Outcome of Board Meeting View filing →
-
7 August 2026 ·
Amendments to Memorandum & Articles of Association
Please refer attached pdf
Company Update / Amendments to Memorandum & Articles of Association View filing →
-
7 August 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Please find enclosed voting results along with scrutinizer's report
AGM/EGM / EGM View filing →
-
5 August 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of EGM
Please find attached proceedings of EGM which was held today i.e., on 5th August, 2026
AGM/EGM / EGM View filing →
-
3 August 2026 ·
Newspaper Clippings - Special Window For Re-Lodgement Of Transfer Requests Of Physical Shares And Dematerialisation
Please refer attached pdf.
Company Update / General View filing →
-
3 August 2026 ·
Board Meeting Intimation for Meeting To Be Held On August 10, 2026.
Ind-Swift Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve Un-Audited Financial ....
Board Meeting / Board Meeting View filing →
-
29 July 2026 ·
Corrigendum To The Notice Of 01/2026-27 Extra-Ordinary General Meeting ('EGM Notice') Dated July 10, 2026
Please refer attached pdf.
AGM/EGM / EGM View filing →
-
29 July 2026 ·
Outcome Of The Preferential Issue Committee Of The Board Of Directors Of Ind-Swift Laboratories Limited In Terms Of The Provisions Of Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Please refer attached pdf.
Company Update / General View filing →
-
28 July 2026 ·
Execution Of MOU For Development Of The Warehouse Facility Of The Company
Please refer attached pdf.
Company Update / General View filing →
RSS feed for Ind-Swift Laboratories Ltd · the 50 most recent filings